DoloresAnneSicheriMD

PubMed

• 59 citations
  A randomised comparison of melphalan with prednisone or dexamethasone as induction therapy and dexamethasone or observation as maintenance therapy in multiple myeloma:...
  Chaim Shustik, Andrew Belch, Sue Robinson, Sheldon H. Rubin, Sean Dolan, Michael J. Kovacs, Kuljit Grewal, David Walde, Robert M. Barr, Jonathan Wilson, Kulwant Gill, ...> ;British Journal of Haematology. 2007 Jan 1
• Isolation and characterization of adriamycin-resistant HL-60 cells which are not defective in the initial intracellular accumulation of drug.
  Marsh, W., Sicheri, D., Center, M. S.> ;Cancer Res. 1986 Aug
• Randomized trial of interferon maintenance in multiple myeloma: a study of the National Cancer Institute of Canada Clinical Trials Group.
  Browman, G. P., Bergsagel, D., Sicheri, D., O'Reilly, S., Wilson, K. S., Rubin, S., Belch, A., Shustik, C., Barr, R., Walker, I.> ;J Clin Oncol. 1995 Sep

Journal Articles

• A Randomized Comparison of Melphalan with Prednisone or Dexamethasone as Induction Therapy and Dexamethasone or Observation as Maintenance Therapy in Multiple Myeloma  
  C Shustik, A Belch, S Robinson, S Rubin, S Dolan, M Kovacs, K Grewal, D Walde, R Barr, J Wilson, K Gill, L Vickars, L Rudinskas, D Sicheri, K Wilson, M Djurfeldt, L Sh..., Br J Haematol, 1/1/2007
• A Phase 1 dose escalation study of a humanized monoclonal antibody to EGFR(hR3) in patients with locally advanced squamous cell cancer of the head and neck(SCCHN) tre...  
  A. Nabid, P Gamguly, V Venkatesan, K Schneider, D. Sicheri, J MacKinnon, S Laurie, E Winquist, International Journal of Radiation Oncology, Biology and Physics, 1/1/2002
• Isolation and Characterization of HL 60, leukemia cells which exhibit a novel mechanism for resistance to Adriamycin  
  Marsh WB, Sicheri, DA, and Center, MS, Cancer Research, 1/1/1986

Books/Book Chapters

• Medical Care of the Surgical Patient, Vol. III 
  Chapter: Medical Care of the Surgical Patient (Oncology) 
  Epstein, R.B., Sicheri, D.A., Organ, C.H.Editors: S. Papper, G.R. Williams.Little Brown, Boston, MA1985

Abstracts/Posters

• A phase I dose escalation study of a humanized monoclonal antibody to epidermal growth factor receptor in previously untreated head and neck cancer.
  E. Winquist, A. Nabid, D. Sicheri, P. Ganguly, V. Venkatesan, Schneider K, MacKinnon J., Laurie, S., ASCO, 1/1/2002
• Experimental Meningeal Carcinomatosis in Canines
  Sicheri, D.A., AACR Proceedings; ACP Regional Meeting, Afton, OK, 1/1/1985

Lectures

• Molecular Basis of Neoplasia 
  1/1/2016
• Randomized Trial of Interferon Maintenance in Multiple Myeloma: A Study of the National Cancer Institute of Canada Clinical Trials Group 
  1/1/1993
• Hemolytic Uremic Syndrome (HUS) with Chemotherapy 
  Afton, OK - 1/1/1987
• Allogenic Bone Marrow Transplantation at the University of Oklahoma 
  Afton, OK - 1/1/1984
• Join now to see all

Other

• Provincial guidelines for Cervical Cancer 
  Sicheri, D.A.
  1/1/2016
• Provincial guidelines for Ovarian Cancer 
  Sicheri, D.A.
  1/1/2016
• Oncology Syllabus 
  Sicheri, D.A.
  University of Oklahoma - 1/1/1983
• Provincial Guidelines for Thyroid Cancer 
  Sicheri, D.A.
• Join now to see all